
JPMorgan Sees Credit Risks Rising as Trade War Bites
The Credit Edge by Bloomberg Intelligence
Navigating Investment Opportunities in the Pharmaceutical Sector
This chapter explores the evolving investment-grade landscape, moving away from traditional sectors such as department stores towards the pharmaceutical industry. The discussion highlights investment strategies centered around companies known for acquisitions and subsequent deleveraging, with a positive outlook on specific pharma firms amid challenges.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.